Eupraxia Pharmaceuticals (EPRX.TO) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.34
-0.28
-0.23
-0.17

Details

Expected EPS
-0.25914701473115
Actual EPS
-0.33671625966615
Surprise EPS
-0.08
Surprise Percent
+29.93%

Description

Eupraxia Pharmaceuticals (EPRX.TO) has reported earnings of -0.33671625966615 per share for Q3 2025.

0 Comments

Share your thoughts